ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
ACHIEVE LIFE SCIENCES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$6.61+0.23 (+3.53%)
Close on Oct 19, 2026
- Market cap
- $617.64M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Jul 31, 2020 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| May 24, 2018 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Nov 9, 2017(first seen in filings) | 1-for-1410 reverse | Earlier per-share figures multiplied by 1410 |
| Aug 3, 2017 | 1-for-11 reverse | Earlier per-share figures multiplied by 11 |
| Aug 21, 2008 | 1-for-18 reverse | Earlier per-share figures multiplied by 18 |